124.17MMarket Cap-1.53P/E (TTM)
1.980High1.970Low1.91KVolume1.980Open1.950Pre Close3.76KTurnover3.00052wk High0.01%Turnover Ratio63.03MShares1.25052wk Low-1.29EPS TTM41.08MFloat Cap3.800Historical HighLossP/E (Static)20.85MShs Float1.250Historical Low-1EPS LYR0.51%Amplitude--Dividend TTM0.94P/B1Lot Size--Div YieldTTM
Palisades Goldcorp Ltd Stock Forum
Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical firm dedicated to developing innovative therapeutics for autoimmune, inflammatory, and fibrotic diseases, has provided an update on its collaboration with Strand Life Sciences ("Strand"), a prominent bioinformatics specialist. This partnership is focused on enhancing precision medicine for ulcerative colitis (UC)...
No comment yet